Temozolomide-Associated Bronchiolitis Obliterans Organizing Pneumonia Successfully Treated with High-Dose Corticosteroid.
10.3346/jkms.2012.27.4.450
- Author:
Tae Ok KIM
1
;
In Jae OH
;
Hyun Wook KANG
;
Su Young CHI
;
Hee Jung BAN
;
Yong Soo KWON
;
Kyu Sik KIM
;
Yu Il KIM
;
Sung Chul LIM
;
Young Chul KIM
Author Information
1. Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea. droij@chonnam.ac.kr
- Publication Type:Case Reports
- Keywords:
Bronchiolitis Obliterans Organizing Pneumonia (BOOP);
Temozolomide;
Methylprednisolone
- MeSH:
Antineoplastic Agents, Alkylating/*adverse effects/therapeutic use;
Cryptogenic Organizing Pneumonia/*chemically induced/*drug therapy/radiography;
Dacarbazine/adverse effects/*analogs & derivatives/therapeutic use;
Dyspnea/etiology;
Female;
Glioblastoma/drug therapy/radiography;
Glucocorticoids/*therapeutic use;
Humans;
Methylprednisolone/therapeutic use;
Middle Aged;
Tomography, X-Ray Computed
- From:Journal of Korean Medical Science
2012;27(4):450-453
- CountryRepublic of Korea
- Language:English
-
Abstract:
Temozolomide is an oral alkylating agent with clinical activity against glioblastoma multiforme (GM). It is generally well-tolerated and has few pulmonary side effects. We report a case of temozolomide-associated brochiolitis obliterans organizing pneumonia (BOOP) requiring very high-dose corticosteroid treatment. A 56-yr-old woman presented with a 2-week history of exertional dyspnea. For the treatment of GM diagnosed 4 months previously, she had undergone surgery followed by chemoradiotherapy, and then planned adjuvant chemotherapy with temozolomide. After the 1st cycle, progressive dyspnea was gradually developed. Chest radiograph showed diffuse patchy peribronchovascular ground-glass opacities in both lungs. Conventional dose of methylprednisolone (1 mg/kg/day) was begun for the possibility of BOOP. Although transbronchial lung biopsy findings were compatible with BOOP, the patient's clinical course was more aggravated until hospital day 5. After the dose of methylprednisolone was increased (500 mg/day for 5 days) radiologic findings were improved dramatically.
